Baltimore, MD – On Friday, the FDA issued warnings over two malaria drugs that have been touted by President Trump. The drugs, hydroxychloroquine and chloroquine, have both been mentioned as potential treatments for the coronavirus. Now, the FDA is urging caution due to recent events with their usage.
In their information, the FDA states that there are concerns about serious heart rhythm issues for individuals that may take the medications. The FDA does not say that providers should not use the medications, but they are urging caution.
Providers were urged to monitor patients closely who may be under the clinical trials or treatment for COVID-19 with these medications. They remind everyone that there is no proven treatment or vaccine for the coronavirus yet. But these are things that we all already knew.
While the main stream media outlets will jump on this information, one must give thought on the larger scale. Any medication that is given has the risks of potential side effects. Just because there may be side effects, does not mean that they should not be utilized. The FDA does not restrict the use of the drugs. But you will not hear this from the media.
Instead, you’re going to continue to hear the Trump bashing story that they want to run. They continue to attack any measure to help in the fight against coronavirus other than continuing shut downs.
Measures continue across the country to attempt to reopen the economy. Amid the push, some polls show that Americans may not want to reopen the economy so soon.
President Trump laid out plans for a potential opening of the economy last week. Many states have followed the plans and have announced measures to open.
While the plans continue to be put into place, millions of Americans continue to be out of work. On the most recent Department of Labor report, nearly 26 million Americans are now out of work.
You can contact JD through The Liberty Loft’s website or by Twitter. If you like what you read, please consider donating to support The Liberty Loft so we can continue to deliver great content.
